Sandy Spring Bank Has $1.08 Million Stake in Becton, Dickinson and Company (BDX)

Sandy Spring Bank raised its holdings in shares of Becton, Dickinson and Company (NYSE:BDX) by 7.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,541 shares of the medical instruments supplier’s stock after acquiring an additional 407 shares during the quarter. Sandy Spring Bank’s holdings in Becton, Dickinson and were worth $1,082,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also modified their holdings of the company. Profund Advisors LLC boosted its stake in shares of Becton, Dickinson and by 14.4% during the 2nd quarter. Profund Advisors LLC now owns 9,963 shares of the medical instruments supplier’s stock worth $1,944,000 after acquiring an additional 1,251 shares during the last quarter. Stevens Capital Management LP purchased a new position in shares of Becton, Dickinson and during the 2nd quarter worth $8,918,000. Investment Centers of America Inc. boosted its stake in shares of Becton, Dickinson and by 15.6% during the 2nd quarter. Investment Centers of America Inc. now owns 4,534 shares of the medical instruments supplier’s stock worth $891,000 after acquiring an additional 612 shares during the last quarter. Amalgamated Bank boosted its stake in shares of Becton, Dickinson and by 66.1% during the 2nd quarter. Amalgamated Bank now owns 26,411 shares of the medical instruments supplier’s stock worth $5,153,000 after acquiring an additional 10,512 shares during the last quarter. Finally, Comerica Securities Inc. boosted its stake in shares of Becton, Dickinson and by 14.8% during the 2nd quarter. Comerica Securities Inc. now owns 1,826 shares of the medical instruments supplier’s stock worth $356,000 after acquiring an additional 236 shares during the last quarter. Institutional investors and hedge funds own 87.12% of the company’s stock.

In related news, insider Gary M. Cohen sold 15,512 shares of the stock in a transaction on Monday, September 11th. The shares were sold at an average price of $203.77, for a total transaction of $3,160,880.24. Following the sale, the insider now directly owns 95,781 shares of the company’s stock, valued at $19,517,294.37. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Ellen R. Strahlman sold 9,283 shares of the stock in a transaction on Thursday, August 10th. The stock was sold at an average price of $198.21, for a total transaction of $1,839,983.43. Following the sale, the insider now directly owns 26,638 shares in the company, valued at $5,279,917.98. The disclosure for this sale can be found here. Insiders have sold 75,904 shares of company stock worth $15,242,688 over the last three months. 1.40% of the stock is currently owned by insiders.

Becton, Dickinson and (NYSE:BDX) last announced its quarterly earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.44 by $0.02. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. The firm had revenue of $3.04 billion for the quarter, compared to the consensus estimate of $3.06 billion. During the same period in the prior year, the firm posted $2.35 earnings per share. The firm’s quarterly revenue was down 5.1% compared to the same quarter last year.

The company also recently declared a quarterly dividend, which was paid on Friday, September 29th. Investors of record on Friday, September 8th were issued a dividend of $0.73 per share. This represents a $2.92 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date of this dividend was Thursday, September 7th. Becton, Dickinson and’s dividend payout ratio (DPR) is presently 83.43%.

ILLEGAL ACTIVITY NOTICE: This piece was published by Stock Observer and is the sole property of of Stock Observer. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The correct version of this piece can be accessed at https://www.thestockobserver.com/2017/10/13/sandy-spring-bank-has-1-08-million-stake-in-becton-dickinson-and-company-bdx.html.

Several brokerages have recently weighed in on BDX. Barclays PLC reiterated an “equal weight” rating and set a $210.00 price target (up previously from $205.00) on shares of Becton, Dickinson and in a research note on Thursday, August 10th. BidaskClub cut shares of Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Piper Jaffray Companies reiterated a “buy” rating and set a $213.00 price target on shares of Becton, Dickinson and in a research note on Tuesday, September 12th. Stifel Nicolaus reiterated a “buy” rating on shares of Becton, Dickinson and in a research note on Wednesday, August 9th. Finally, Zacks Investment Research cut shares of Becton, Dickinson and from a “buy” rating to a “hold” rating in a research note on Monday, August 7th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company’s stock. Becton, Dickinson and currently has an average rating of “Buy” and an average price target of $200.93.

Becton, Dickinson and Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply